Phase IIA Exploratory Study of Oral Milciclib Maleate in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Milciclib (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- Sponsors Tiziana Life Sciences
- 11 Dec 2017 According to a Tiziana Life Sciences media release, independent data monitor committee (IDMC) completed interim analysis from the first six patients, and recommended continuing with the trial.
- 19 Jul 2017 According to a Tiziana Life Sciences media release, first patient has been enrolled and top line data from this trial is expected in Q4 2018.
- 07 Jun 2017 Status changed from not yet recruiting to recruiting.